Obamacare levies an excise tax on medical devices that will reduce research & development investment by over $2 billion every year, beginning in 2013. This will have an impact on patients' health. An initial estimate figures that this will cause a loss of one million life-years annually.
Read this month's Health Policy Prescription, by Benjamin Zycher, at this link.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment